Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets
The Science
What is the Brain Blend?
The Brain Blend layers three orally formulated research compounds targeting cognitive and neurological pathways: Dihexa (a hepatocyte growth factor/c-Met activator), Tesofensine (a triple monoamine reuptake inhibitor), and BPC-157 (a gastric pentadecapeptide with research interest in gut-brain signaling).
Dihexa is a small-molecule angiotensin IV analog investigated for potentiating hepatocyte growth factor (HGF) signaling at the c-Met receptor, supporting synaptogenesis in laboratory models.
Tesofensine inhibits reuptake of dopamine, serotonin, and norepinephrine, increasing monoaminergic signaling in the central nervous system. BPC-157, even in oral form, has shown stability in gastric fluid and is investigated for vagal/gut-brain axis effects.
Laboratory Observations
Key Observed Effects in Research
Synaptogenic Signaling
Dihexa demonstrates dendritic spine formation in hippocampal slice models.
Monoaminergic Tone
Tesofensine research shows elevation of synaptic dopamine, serotonin, and norepinephrine.
Gut Barrier Models
Oral BPC-157 supports gut barrier integrity in rodent models.
Mechanism of Action
Three Neurological Research Pathways
The blend stacks distinct mechanisms relevant to synaptic plasticity, monoamine neurotransmission, and gut-brain signaling.
HGF/c-Met Potentiation
Dihexa is investigated for amplifying HGF signaling at the c-Met receptor, supporting dendritic spine formation in hippocampal culture models.
Monoamine Reuptake Inhibition
Tesofensine blocks reuptake of dopamine, serotonin, and norepinephrine, elevating synaptic neurotransmitter availability.
Gut-Brain Axis
Oral BPC-157 is investigated for vagal afferent modulation and gut barrier protection relevant to gut-brain signaling.
Oral Bioavailability
Tablet formulation supports research into oral pharmacokinetics of each component.
FAQ
Frequently Asked Questions
What is the c-Met receptor?+
c-Met is the receptor for hepatocyte growth factor (HGF). Dihexa research focuses on its ability to potentiate HGF/c-Met signaling, which has been linked to synaptogenesis and dendritic spine formation in neuronal culture.
Research-Only Notice
Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.